New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

She was diagnosed with alopecia areata, an autoimmune condition that disrupts regular hair growth, at just 18 months old and ...

Long, lustrous hair is a universal desire, but the journey to achieve it often leads people to the vitamin aisle. Shelves are ...

Here comes the sunscreen—and the hats, and the protective clothing. For our edit of the year’s very best, we joined forces with a panel of top dermatologists and together tested hundreds of SPF ...

Long, lustrous hair is a universal desire, leading many to seek hope in the vitamin aisle, where shelves are packed with bottles promising thicker and faster-growing hair. However, the burning ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.